Bank of America Corporation »

Bridgebio Oncology Therapeut shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $588k 77k 7.62

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Bank of America Corporation

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
EcoR1 Capital
Alphabet
Wellington Management Company
Enavate Sciences GP
Citadel Advisors
Novo A/S
BlackRock
Vanguard Capital Management
Laurion Capital Management
Armistice Capital
Aisling Capital Management
Opaleye Management

View all funds holding Bridgebio Oncology Therapeut